Jul 28, 2010
29:25
For every 25 shares held, investors received 29. The price per share adjusted from $59.20 to $51.03.
The split itself did not change the total investment value.
Orient Europharma Co., Ltd. (TPEX:4120) operates in the Pharmaceuticals: major industry.
Orient Europharma Co., Ltd. company overviewOrient Europharma Co., Ltd.'s most recent stock split was on July 28, 2010. It was a 29-for-25 forward split, so shareholders received 29 shares for every 25 they held.
Orient Europharma Co., Ltd. (TPEX:4120) has split its stock 7 times: a 103-for-100 split on July 29, 2004, a 101-for-100 split on September 12, 2005, a 103-for-100 split on July 19, 2006, a 245-for-223 split on September 12, 2007, a 11-for-10 split on July 29, 2008, a 619-for-542 split on August 13, 2009, and a 29-for-25 split on July 28, 2010.
Orient Europharma Co., Ltd. has split its stock 7 times. This history records 7 forward splits between July 29, 2004 and July 28, 2010.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Orient Europharma Co., Ltd.'s 29-for-25 split on July 28, 2010, every 25 shares became 29 shares.
Orient Europharma Co., Ltd. has not announced a new split in our records. Its most recent split was on July 28, 2010, 16 years ago. Companies announce splits in advance, and any new TPEX:4120 split will appear on this page.
Already premium?